An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults

An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults

Background: While the world is experiencing another wave of COVID-19 pandemic, global vaccination program is hampered by an evident shortage in the supply of licensed vaccines. In an effort to satisfy vaccine demands we developed a new single-dose vaccine based on recombinant adenovirus type 26 (rAd...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amir I. Tukhvatulin, Inna V. Dolzhikova, Dmitry V. Shcheblyakov, Olga V. Zubkova, Alina S. Dzharullaeva, Anna V. Kovyrshina, Nadezhda L. Lubenets, Daria M. Grousova, Alina S. Erokhova, Andrei G. Botikov, Fatima M. Izhaeva, Olga Popova, Tatiana A. Ozharovskaia, Ilias B. Esmagambetov, Irina A. Favorskaya, Denis I. Zrelkin, Daria V. Voronina, Dmitry N. Shcherbinin, Alexander S. Semikhin, Yana V. Simakova, Elizaveta A. Tokarskaya, Maksim M. Shmarov, Natalia A. Nikitenko, Vladimir A. Gushchin, Elena A. Smolyarchuk, Tatiana G. Zubkova, Konstantin A. Zakharov, Vasiliy B. Vasilyuk, Sergei V. Borisevich, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Public aspects of medicine
RA1-1270
Acceso en línea:https://doaj.org/article/54fc97d8b69745aa9da8b8b6bf909e3d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/54fc97d8b69745aa9da8b8b6bf909e3d

Ejemplares similares